Biomonitoring of workers employed in a titanium dioxide production plant: Use of buccal micronucleus cytome assay as noninvasive biomarker to evaluate genotoxic and cytotoxic effects
- PMID: 33720463
- DOI: 10.1002/em.22431
Biomonitoring of workers employed in a titanium dioxide production plant: Use of buccal micronucleus cytome assay as noninvasive biomarker to evaluate genotoxic and cytotoxic effects
Abstract
We aimed to evaluate whether TiO2 production process induces genotoxic and cytotoxic effects on the first target organ of inhalable particles by a sensitive and noninvasive biomarker of effect. Final aim was to find a useful and suitable tool to assess and manage the risk of TiO2 occupational exposure. We enrolled 40 workers employed in TiO2 production, 5 office workers, and 18 external controls. Buccal micronucleus cytome assay (BMCyt assay) was applied because it allows to evaluate micronucleus (MN), nuclear buds (NB), and broken eggs (BE) indicating the presence of chromosomal instability and gene amplification and binucleated cells (BIN), karyolytic cells (KL), and condensed chromatin (CC) indicating cytokinesis defect or arrest, cell death and apoptosis respectively. We characterized the exposure measuring inhalable and respirable particles by personal monitoring. BMCyt-assay showed in exposed workers compared with external controls a higher value of MN frequency (2.57 vs. 0.05‰, p < .001) and MN positivity, evaluated as percentage of subjects with MN frequency higher than a 1.5‰ cut-off value (52.5 vs. 0%). We also found in exposed workers higher frequency of BE + NB (2.41 vs. 0.22‰, p = .002), BIN (9.45 vs. 8.44‰, p = .047) and CC (1.80 vs. 0.21, p = .001) than in controls. Moreover, we found a relationship between personal monitoring results and presence of MN and other cellular anomalies. This study demonstrates induction of genotoxic and cytotoxic effects on buccal cells of workers involved in TiO2 production, suggesting the suitability of BMCyt assay as tool for risk assessment and management of TiO2 exposure.
Keywords: TiO2 particles; buccal micronucleus cytome assay (BMCyt assay); cytotoxicity; genotoxicity; occupational exposure; personal monitoring.
© 2021 Environmental Mutagen Society.
References
REFERENCES
-
- ACGIH. (2001) Titanium dioxide. In: Documentation of the Threshold Limit Values for Chemical Substances, 7th edition. Cincinnati, OH: American Conference of Governmental Industrial Hygienists.
-
- Andreoli, C., Leter, G., de Berardis, B., Degan, P., de Angelis, I., Pacchierotti, F., Crebelli, R., Barone, F. and Zijno, A. (2018) Critical issues in genotoxicity assessment of TiO2 nanoparticles by human peripheral blood mononuclear cells. Journal of Applied Toxicology, 38, 1471-1482.
-
- Basinas, I., Jimenez, A.S., Galea, K.S., Tongeren, M.V. and Hurley, F. (2018) A systematic review of the routes and forms of exposure to engineered nanomaterials. Annals of Work Exposures and Health, 62, 639-662.
-
- Bonassi, S., Coskun, E., Ceppi, M., Lando, C., Bolognesi, C., et al. (2011). The HUman MicroNucleus project on eXfoLiated buccal cells (HUMN(XL)): the role of life-style, host factors, occupational exposures, health status, and assay protocol. Mutat. Res. 728(3), 88-97. https://doi.org/10.1016/j.mrrev.2011.06.005.
-
- Braakhuis, H.M., Gosens, I., Heringa, M.B., Oomen, A.G., Vandebriel, R.J., Groenewold, M. and Cassee, F.R. (2021) Mechanism of action of TiO2: recommendations to reduce uncertainties related to carcinogenic potential. Annual Review of Pharmacology and Toxicology, 61, 203-223. https://doi.org/10.1146/annurev-pharmtox-101419-100049
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical